Ali Behbahani
Director · CRISPR Therapeutics AG
Individual
- 2024
- Sep 21, 2026
- 20
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Ali Behbahani files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Samarth Kulkarni - $10.47M in CRSP purchases and sales in the last 12 months
- Raju Prasad - $5.10M in CRSP purchases and sales in the last 12 months
- James R. Kasinger - $1.32M in CRSP purchases and sales in the last 12 months
- Naimish Patel - $412K in CRSP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Ali Behbahani?
Ali Behbahani is a corporate insider, tracked as Director of CRISPR Therapeutics AG (CRSP). InsiderAlpha holds 20 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Ali Behbahani submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Ali Behbahani been buying or selling stock?
Recorded transactions: 4 open-market purchases ($15.00M) and 6 open-market sales ($256K) across all tracked filings.
